Water Quality in VICTORIA, TX (77905)
EPA violation data for public water systems serving ZIP code 77905.
310
Total Violations
53
Health-Based
257
Monitoring / Reporting
283
Resolved
What does this mean?
283 of 310 violations have been resolved. 53 are health-based violations, meaning contaminant levels exceeded federal safety limits. The remaining 257 are monitoring or reporting violations (missed testing deadlines or late paperwork — not necessarily a water quality issue). Not all violations mean your water is unsafe. The EPA requires reporting even for minor administrative issues.
Violations Detail (310 total)
| Contaminant | Category | MCL Limit | Measured | Date | Status | Health Effects |
|---|---|---|---|---|---|---|
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 7, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | Jun 30, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 27, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 26, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 26, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 9, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 5, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 5, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2025 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Health-Based | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| LEAD AND COPPER RULE REVISIONS | Monitoring | N/A | N/A | Oct 16, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 28, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Sep 3, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 3, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Sep 3, 2024 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Aug 17, 2024 | Active | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2024 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Dec 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2023 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2023 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.04 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.04 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.04 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.04 | Jun 30, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 8, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 7, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.045 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.045 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.045 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.045 | Mar 31, 2023 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jan 14, 2023 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.013 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Arsenic | Health-Based | N/A | 0.049 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.049 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.049 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.049 | Dec 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.011 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.031 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.031 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.031 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.031 | Sep 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 20, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.026 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.026 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.026 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.026 | Jun 30, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Arsenic | Health-Based | N/A | 0.014 | Mar 31, 2022 | Resolved | Skin damage; circulatory system problems; increased risk of cancer |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 29, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Consumer Confidence Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | May 12, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 12, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 12, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | May 12, 2021 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
Lead & Copper Levels
Violation Timeline
2025(29)
Lead and Copper Rule
66
Public Notice
75
Revised Total Coliform Rule
2C
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
2C
Revised Total Coliform Rule
2C
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Lead and Copper Rule
66
Lead and Copper Rule
66
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2024(38)
Lead and Copper Rule
66
Lead and Copper Rule
66
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
2E
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
LEAD AND COPPER RULE REVISIONS
4G
Lead and Copper Rule
66
Lead and Copper Rule
66
Lead and Copper Rule
66
E. COLI
34
E. COLI
34
E. COLI
34
Public Notice
75
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
2023(65)
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Nitrate
03
Nitrate
03
Nitrate
03
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Public Notice
75
2022(80)
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Public Notice
75
Public Notice
75
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Lead and Copper Rule
52
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Lead and Copper Rule
52
Lead and Copper Rule
52
Lead and Copper Rule
52
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Public Notice
75
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Public Notice
75
Public Notice
75
Public Notice
75
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Arsenic
02
Public Notice
75
Public Notice
75
Public Notice
75
Public Notice
75
2021(98)
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Public Notice
75
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Consumer Confidence Rule
71
Consumer Confidence Rule
71
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
E. COLI
34
E. COLI
34
E. COLI
34
E. COLI
34
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Public Notice
75
Public Notice
75
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Nitrate
03
Nitrate
03
Nitrate
03
Nitrate
03
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
Revised Total Coliform Rule
3A
How Does This Compare?
VICTORIA (77905) has 310 recorded violations, including 53 health-based. 27 remain unresolved. Consider testing your tap water independently for added peace of mind.
Recommended Water Filters
Based on the contaminants detected in your area, these filter types may help improve your water quality.
Reverse Osmosis System
Highly effective at removing heavy metals, dissolved solids, and a wide range of contaminants. Recommended for homes with lead or arsenic concerns.
Targets:Lead, Copper, Arsenic, Mercury, Cadmium
Look for:NSF/ANSI 58 certified
UV Water Purifier
Uses ultraviolet light to neutralize bacteria, viruses, and parasites without chemicals. Ideal for homes with microbial contamination concerns.
Targets:E. coli, Coliform, Giardia, Cryptosporidium
Look for:NSF/ANSI 55 (Class A) certified
Always look for filters certified by NSF International for the specific contaminants you want to remove.